Literature DB >> 17069513

Quality assessment of Affymetrix GeneChip data.

Steffen Heber1, Beate Sick.   

Abstract

Affymetrix GeneChips are one of the best established microarray platforms. This powerful technique allows users to measure the expression of thousands of genes simultaneously. However, a microarray experiment is a sophisticated and time consuming endeavor with many potential sources of unwanted variation that could compromise the results if left uncontrolled. Increasing data volume and data complexity have triggered growing concern and awareness of the importance of assessing the quality of generated microarray data. In this review, we give an overview of current methods and software tools for quality assessment of Affymetrix GeneChip data. We focus on quality metrics, diagnostic plots, probe-level methods, pseudo-images, and classification methods to identify corrupted chips. We also describe RNA quality assessment methods which play an important role in challenging RNA sources like formalin embedded biopsies, laser-micro dissected samples, or single cells. No wet-lab methods are discussed in this paper.

Entities:  

Mesh:

Year:  2006        PMID: 17069513     DOI: 10.1089/omi.2006.10.358

Source DB:  PubMed          Journal:  OMICS        ISSN: 1536-2310


  43 in total

1.  Quantitative expression profiling in formalin-fixed paraffin-embedded samples by affymetrix microarrays.

Authors:  Diana Abdueva; Michele Wing; Betty Schaub; Timothy Triche; Elai Davicioni
Journal:  J Mol Diagn       Date:  2010-06-03       Impact factor: 5.568

Review 2.  Standards affecting the consistency of gene expression arrays in clinical applications.

Authors:  Steven A Enkemann
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2010-03-23       Impact factor: 4.254

3.  Susceptibility loci for lung cancer are associated with mRNA levels of nearby genes in the lung.

Authors:  Justin Dang Uy Nguyen; Maxime Lamontagne; Christian Couture; Massimo Conti; Peter D Paré; Don D Sin; James C Hogg; David Nickle; Dirkje S Postma; Wim Timens; Michel Laviolette; Yohan Bossé
Journal:  Carcinogenesis       Date:  2014-09-03       Impact factor: 4.944

4.  Data integration in genetics and genomics: methods and challenges.

Authors:  Jemila S Hamid; Pingzhao Hu; Nicole M Roslin; Vicki Ling; Celia M T Greenwood; Joseph Beyene
Journal:  Hum Genomics Proteomics       Date:  2009-01-12

5.  A decreased ratio of laminin-332 beta3 to gamma2 subunit mRNA is associated with poor prognosis in colon cancer.

Authors:  Cherise M Guess; Bonnie J Lafleur; Brandy L Weidow; Vito Quaranta
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2009-04-21       Impact factor: 4.254

6.  Using the ratio of means as the effect size measure in combining results of microarray experiments.

Authors:  Pingzhao Hu; Celia M T Greenwood; Joseph Beyene
Journal:  BMC Syst Biol       Date:  2009-11-05

7.  Disordered macrophage cytokine secretion underlies impaired acute inflammation and bacterial clearance in Crohn's disease.

Authors:  Andrew M Smith; Farooq Z Rahman; Bu'Hussain Hayee; Simon J Graham; Daniel J B Marks; Gavin W Sewell; Christine D Palmer; Jonathan Wilde; Brian M J Foxwell; Israel S Gloger; Trevor Sweeting; Mark Marsh; Ann P Walker; Stuart L Bloom; Anthony W Segal
Journal:  J Exp Med       Date:  2009-08-03       Impact factor: 14.307

8.  Quality control in microarray assessment of gene expression in human airway epithelium.

Authors:  Tina Raman; Timothy P O'Connor; Neil R Hackett; Wei Wang; Ben-Gary Harvey; Marc A Attiyeh; David T Dang; Matthew Teater; Ronald G Crystal
Journal:  BMC Genomics       Date:  2009-10-24       Impact factor: 3.969

9.  New methods to analyse microarray data that partially lack a reference signal.

Authors:  Neeltje Carpaij; Ad C Fluit; Jodi A Lindsay; Marc Jm Bonten; Rob Jl Willems
Journal:  BMC Genomics       Date:  2009-11-13       Impact factor: 3.969

10.  Unsupervised assessment of microarray data quality using a Gaussian mixture model.

Authors:  Brian E Howard; Beate Sick; Steffen Heber
Journal:  BMC Bioinformatics       Date:  2009-06-22       Impact factor: 3.169

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.